What (who) is Regenerelle™
Regenerelle is the name of a company, founded in 2020, who conceptualized and launched a suite of Wharton’s jelly products. They developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. Regenerelle™ portfolio of products includes, WJ-MSCs, EVs and growth media.
Regenerelle’s™ standard of excellence:
Regenerelle™ stem cells and exosomes are the gold standard of UC-MSCs (umbilical cord – Mesenchymal Cells). Patients can expect the highest potency and purity, with stringent GMP FDA quality testing at every step of the process of isolation, expansion, harvest and cryostorage with this lab. At Optimal, we have moved to Rengenerelle’s products including Wharton’s Jelly.